Compass Pathways PLC (FRA:5Y6)
€ 4.26 0 (0%) Market Cap: 291.47 Mil Enterprise Value: 126.62 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 38/100

Compass Pathways PLC at JMP Securities Life Sciences Virtual Conference Transcript

Jun 16, 2021 / 02:30PM GMT
Release Date Price: €30.5 (-2.87%)
Jason Butler
JMP Securities LLC - Analyst

Great, and thank you again for everybody joining us this morning at the JMP Securities life science conference. Excited to have COMPASS Pathways presenting to us next. Joining us will be both Lars Wilde, the Company's President and Chief Business Officer; and Stephen Schultz, the Company's Head of IR. So thank you to both of you for joining.

COMPASS, obviously, had a really exciting last few months with the IPO and really making progress with obviously a clear unmet medical need in depression patients with really resistant symptoms. So Lars, appreciate all the work that you are doing, your novel approach to this important indication, and I will turn it over to you. Thank you.

Lars Wilde;Founder
COMPASS Pathways plc - President, Chief Business Officer, and Coâ

Jason, thanks so much for having us. Thank you for JMP Securities for inviting us to the conference and giving us the opportunity to speak about our work at COMPASS Pathways. We are all about transforming mental health care, and I want

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot